Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Qiagen N.V. (QGEN)

  • Business News
  • Nov. 04, 2025, 18:03 UTC
  • 10
  • 1 comments

QIAGEN to acquire Parse Biosciences, expanding its Sample technologies portfolio into highly scalable single-cell solutions

Market reaction Comment Full text

uniQure NV (QURE)

  • Business News
  • Nov. 04, 2025, 17:06 UTC
  • 10
  • 1 comments

NASDAQ: QURE Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm

Market reaction Comment Full text

RedHill Biopharma (RDHL)

  • Business News
  • Nov. 04, 2025, 17:01 UTC
  • 9
  • 1 comments

RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement

Market reaction Comment Full text

Chemed Corp (CHE)

  • Business News
  • Nov. 04, 2025, 17:00 UTC
  • 11
  • 1 comments

Chemed Corporation to Present at the UBS 2025 Global Healthcare Conference

Market reaction Comment Full text

Evoke Pharma Inc. (EVOK)

  • Business News
  • Nov. 04, 2025, 15:07 UTC
  • 11
  • 1 comments

EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders

Market reaction Comment Full text

RedHill Biopharma (RDHL)

  • Business News
  • Nov. 04, 2025, 14:30 UTC
  • 16
  • 1 comments

RedHill Announces $10.5 Million New York Supreme Court Judgment Win Now Final for Enforcement

Market reaction Comment Full text

SOHM, Inc. (SHMN)

  • Business News
  • Nov. 04, 2025, 14:30 UTC
  • 17
  • 1 comments

SOHM Notes FDA’s Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development.

Market reaction Comment Full text

Akari Therapeutics plc (AKTX)

  • Business News
  • Nov. 04, 2025, 14:25 UTC
  • 21
  • 1 comments

Akari Therapeutics’ Accepted Abstract Showcasing its Novel Splicing-Targeted ADC Payload Driving Immune Activation Now Available

Market reaction Comment Full text

LifeMD Inc (LFMD)

  • Business News
  • Nov. 04, 2025, 14:15 UTC
  • 21
  • 1 comments

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

Market reaction Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Business News
  • Nov. 04, 2025, 14:15 UTC
  • 20
  • 1 comments

CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

Market reaction Comment Full text
  • Previous
  • 889
  • 890
  • 891
  • 892
  • 893
  • Next

Search

News categories

  • Technical Exchange News(11000)
  • Event(2489)
  • SEC News(194846)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126733)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin